Preclinical Evaluation of Tumor Microvascular Response to a Novel Antiangiogenic/Antitumor Agent RO0281501 by Dynamic Contrast-Enhanced MRI at 1.5 T
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0010
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2006
Authors
Publisher
American Association for Cancer Research (AACR)